Table 1.
Initial presentationa | Primary Option | Alternative Option |
---|---|---|
Antibiotic use in past month? | No; choose from Amoxicillin 1 g TID | Yes; choose from |
Cefdinir 300 mg Q12 h or 600 mg Q24 h | Augmentin XR 2000/125 mg BID | |
Cefpodoxime 200 mg BID | If allergic to penicillin, choose from | |
Cefprozil 250–500 mg BID | Gatifloxacin 400 mg Q24 h | |
If allergic to penicillin, choose from | Levofloxacin 750 mg Q24 h × 5 d | |
Moxifloxacin 400 mg Q24 h | Moxifloxacin 400 mg Q24 h | |
Doxycycline100 mg BID | ||
TMP-SMX (Bactrim DS), 1 tablet BID | ||
Clarithromycin 500 mg BID or | ||
Clarithromycin ER 1 g Q24 h | ||
Clinical failure after 3 days of initial therapyb | Mild or moderate disease, choose from | Severe disease, choose from |
Augmentin XR 2000/125 mg BID | Gatifloxacin 400 mg Q24 h | |
Cefdinir 300 mg Q12 h or 600 mg Q24 h | Levofloxacin 750mg Q24 h × 5 d | |
Cefpodoxime 200 mg BID | Moxifloxacin 400 mg Q24 h | |
Cefprozil 250–500 mg BID |
All regimens are for 10 days unless otherwise specified. TMP-SMX, trimethoprim and sulfamethoxazole; DS, double strength; ER, extended release.
Patients with fever and facial erythema are at increased risk of infection with Staphylococcus aureus, which warrants intravenous antibiotic therapy.
Consider referral to otolaryngologist for diagnostic aspiration and culture.